Abstract
We analyzed a complex multilevel network of the induction links of regulatory peptides and nonpeptide mediators on the basis of a database that was created using data obtained in 1970–2010 on the physiological and induction effects of these regulators. We determined models of bioinformatic programs that exist inside a continuum of regulatory peptides and mediators. They helped us to understand the main principles of the functioning of various endogenous compounds and to visualize the channels of directed therapeutic control of biological processes. We found the traits of the system of coupled functioning of serotonin and dopamine at several different physiological levels, which designated the nature of the resulting vectors of the two mediators.
Similar content being viewed by others
References
Ashmarin, I.P. and Obukhova, M.F., Vestnik RAMN, 1994, no. 10, pp. 28–34.
Koroleva, S.V. and Ashmarin, I.P., Journal of Theoretical Biology, 2002, vol. 216, no. 3, pp. 257–271.
Koroleva, S.V. and Ashmarin, I.P., Bioorg. Khim., 2006, vol. 32, no. 3, pp. 249–257.
Ashmarin, I.P. and Koroleva, S.V., Dizregulyatsionnaya patologiya nervnoi sistemy., Gusev, E.I and Kryzhanovskii, G.N, Ed., Moscow: Meditsinskoe informatsionnoe agenstvo, 2009.
Koroleva, S.V., Issledovanie strukturno-funktsional’nykh osobennostei kontinuuma regulyatornykh peptidov i mediatorov:, Doctoral (Biol) Dissertation, Moscow: MGU., 2010.
Koroleva, S.V. and Ashmarin, I.P., Patogenez, 2005, vol. 3, no. 3, pp. 11–15.
Koroleva, S.V., Nikolaeva, A.A., and Ashmarin, I.P., Izvestiya Akademii Nauk, Seriya Biologicheskaya, 2006, no. 4, pp. 457–469.
Nikolaeva, A.A., Koroleva, S.V., and Ashmarin, I.P., Neirokhimiya, 2008, vol. 25, no. 3, pp. 191–201.
Elvander, E. and Ogren, S.O., Neuropeptides, 2005, vol. 39, no. 3, pp. 245–248.
Ogren, S.O., Pramanik, A., Land, T., and Langel, U., Eur. J. Pharmacol., 1993, vol. 242, no. 1, pp. 59–64.
Akehira, K., Nakane, Y., Hioki, K., and Taniyama, K., Eur. J. Pharmacol., 1995, vol. 284, nos. 1–2, pp. 149–155.
Nishimura, T. and Akasu, T., Kurume Med. J., 1995, vol. 42, no. 1, pp. 45–48.
Smith-White, M.A., Iismaa, T.P., and Potter, E.K., Br. J. Pharmacol., 2003, vol. 140, no. 1, pp. 170–178.
Pérez-Navarro, E., Alberch, J., and Marsal, J., Int. J. Dev. Neurosci., 1993, vol. 11, no. 6, pp. 701–708.
Hasenöhrl, R.U., Souza-Silva, M.A., Nikolaus, S., Tomaz, C., Brandao, M.L., Schwarting, R.K., and Huston, J.P., Neuropeptides, 2000, vol. 34, no. 5, pp. 272–280.
Lapchak, P.A., Araujo, D.M., Quirion, R., and Beaudet, A., J. Neurochem., 1990, vol. 55, no. 4, pp. 1397–1403.
Torocsik, A., Rakovska, A., Gorcs, T., and Vizi, E.S., Brain Res., 1993, vol. 612, nos. 1–2, pp. 306–312.
Magnani, M., Mantovani, P., and Pepeu, G., Neuropharmacology, 1984, vol. 23, no. 11, pp. 1305–1309.
Soudah, H.C., Lu, Y., Hasler, W.L., and Owyang, C., Am. J. Physiol., 1992, vol. 263, no. 1, pp. G102–107.
Arneric-, S.P. and Reis, D.J., Brain Res., 1986, vol. 374, no. 1, pp. 153–161.
Wood, P.L., Cheney, D.L., and Costa, E., J. Pharmacol. Exp. Ther., 1979, vol. 209, no. 1, pp. 97–103.
Schoffelmeer, A.N., Warden, G., Hogenboom, F., and Mulder, A.H., J. Pharmacol. Exp. Ther., 1991, vol. 258, no. 1, pp. 237–242.
Yokotani, K. and Osumi, Y., Jpn. J. Pharmacol, 1998, vol. 78, no. 1, pp. 93–95.
Hiramatsu, M., Murai, M., and Kameyama, T., Biochem. Pharmacol., 1999, vol. 57, no. 11, pp. 1321–1329.
Oron, L., Sarne, Y., and Michaelson, D.M., Neurosci. Let., 1991, vol. 125, no. 2, pp. 231–234.
Itoh, H., Andoh, T., Watanabe, I., Sasaki, T., Kamiya, Y., and Okumura, F., Eur. J. Neurosci., 2000, vol. 12, no. 4, pp. 1253–1262.
Jhamandas, K. and Sutak, M., Br. J. Pharmacol., 1980, vol. 71, no. 1, pp. 201–210.
Olianas, M.C. and Onali, P., J. Neurochem., 2000, vol. 75, no. 1, pp. 233–239.
Miampamba, M., Maillot, C., Million, M., and Tach, Y., Am. J. Physiol. Gastrointest. Liver Physiol., 2002, vol. 282, no. 5, pp. G857–865.
Barnes, J.M., Barnes, N.M., Costall, B., Horovitz, Z.P., Ironside, J.W., Naylor, R.J., and Williams, T.J., J. Cardiovasc. Pharmacol., 1990, vol. 16, no. 2, pp. 234–238.
Du, X.J., Cox, H.S., Dart, A.M., and Esler, M.D., J. Cardiovasc. Pharmacol., 1998, vol. 31, no. 6, pp. 937–944.
Buffelli, M., Pasino, E., and Cangiano, A., Neuroscience, 2001, vol. 104, no. 2, pp. 561–567.
Rossi, S.G., Dickerson, I.M., and Rotundo, R.L., J. Biol. Chem., 2003, vol. 278, no. 27, pp. 24994–25000.
Liu, D.M., Cuevas, J., and Adams, D.J., Eur. J. Neurosci., 2000, vol. 12, no. 7, pp. 2243–2251.
Liu, Y.C., Khawaja, A.M., and Rogers, D.F., Br. J. Pharmacol., 1999, vol. 128, no. 6, pp. 1353–1359.
Rakovska, A., Javitt, D., Raichev, P., Ang, R., Balla, A., Aspromonte, J., and Vizi, S., Brain Res. Bull., 2003, vol. 61, no. 5, pp. 529–536.
Nakata, A., Saito, H., and Nishiyama, N., Brain Res., 1996, vol. 723, nos. 1–2, pp. 135–140.
Schäfer, J., Baumeister, H., Lorenz, A., and Meyerhof, W., Z. Ernahrungswiss, 1998, vol. 37, no. Suppl 1, pp. 75–79.
Guillemin, R., Endocrinology, 1976, vol. 99, no. 6, pp. 1653–1654.
Toide, K., Shinoda, M., Takase, M., Iwata, K., and Yoshida, H., Eur. J. Pharmacol., 1993, vol. 233, no. 1, pp. 21–28.
Pirola, C.J., Balda, M.S., Finkielman, S., and Nahmod, V.E., Life Sci., 1984, vol. 34, no. 17, pp. 1643–1649.
Messell, T., Harling, H., Poulsen, S.S., Bersani, M., and Holst, J.J., Regul. Pept., 1992, vol. 38, no. 3, pp. 179–198.
McIntosh, C.H., Dadgar, A., and Kwok, Y.N., Regul. Pept., 1992.
Huang, L.Z. and Winzer-Serhan, U.H., Dev. Neurobiol., 2007, vol. 67, no. 3, pp. 363–377.
Sastry, B.V., Clin. Exp. Pharmacol. Physiol., 1995, vol. 22, no. 4, pp. 288–290.
Alburges, M.E., Hoonakker, A.J., and Hanson, G.R., Eur. J. Pharmacol., 2007, vol. 573, nos. 1–3, pp. 124–132.
Inoue, H., Hashimoto, K., and Ota, Z., Acta. Med. Okayama, 1988, vol. 42, no. 2, pp. 61–67.
Toth, M., Ruskoaho, H., and Lang, R.E., J. Hypertens, vol. 4, no. 6, pp. 538–541.
Speake, P.F., Pirie, S.C., Kibble, J.D., Muneer, A., Taylor, D., Birring, S., and Green, R., Clin. Sci. (Lond), 1993, vol. 85, no. 1, pp. 5–12.
Louiset, E., Cazin, L., Duval, O., Lamacz, M., Tonon, M.C., and Vaudry, H., Brain Res., 1990, vol. 533, no. 2, pp. 300–308.
Garnier, M., Lamacz, M., Galas, L., Lenglet, S., Tonon, M.C., and Vaudry, H., Endocrinology, 1998, vol. 139, no. 8, pp. 3525–3533.
Katsura, M., Ohkuma, S., Chen, D.T., Tsujimura, A., and Kuriyama, K., Neurosci. Let., 1994, vol. 168, nos. 1–2, pp. 1–4.
Chan, P., Liu, I.M., Tzeng, T.F., Yang, T.L., and Cheng, J.T., Diabetes Obes. Metab., 2007, vol. 9, no. 1, pp. 39–49.
Genazzani, A.R., Petraglia, F., Facchinetti, F., Golinelli, S., Oltramari, P., Santoro, V., and Volpe, A., J. Clin. Endocrinol. Metab., 1988, vol. 66, no. 2, pp. 279–282.
Dumont, M., Day, R., and Lemaire, S., Life Sci., 1983, vol. 32, no. 3, pp. 287–294.
Ohmori, N., Itoi, K., Tozawa, F., Sakai, Y., Sakai, K., Horiba, N., Demura, H., and Suda, T., Endocrinology, 1995, vol. 136, no. 11, pp. 4858–4863.
Wei, R., Phillips, T.M., and Sternberg, E.M., J. Neuroimmunol., 2002, vol. 131, nos. 1–2, pp. 31–40.
Kubo, T. and Hagiwara, Y., Brain Res., 2005, vol. 1061, no. 1, pp. 36–41.
Hagiwara, Y., Ohi, M., and Kubo, T., Brain Res. Bull., 2005, vol. 67, no. 3, pp. 203–209.
Dussor, G.O., Leong, A.S., Gracia, N.B., Kilo, S., Price, T.J., Hargreaves, K.M., and Flores, C.M., Eur. J. Neurosci., 2003, vol. 18, no. 9, pp. 2515–2526.
Bernardini, N., Reeh, P.W., and Sauer, S.K., Neuroreport, 2001, vol. 12, no. 11, pp. 2457–2460.
Henning, R.J. and Sawmiller, D.R., Cardiovasc Res., 2001, vol. 49, no. 1, pp. 27–37.
Pelat, M., Lazartigues, E., Tran, M.A., Gharib, C., Montastruc, J.L., Montastruc, P., and Rascol, O., Eur. J. Pharmacol., 1999, vol. 379, nos. 2–3, pp. 117–124.
Shioda, S., Yada, T., Muroya, S., Takigawa, M., and Nakai, Y., Neurosci Res., 1997, vol. 29, no. 4, pp. 311–318.
Shen, E. and Sun, X., Neurosci. Let., 1995, vol. 195, no. 3, pp. 191–194.
Hall, T.R., Harvey, S., and Chadwick, A., Gen. Pharmacol., 1985, vol. 16, no. 5, pp. 483–488.
Gürün, M.S., Savci, V., Ulus, I.H., and Kiran, B.K., Neurosci. Let., 1997, vol. 232, no. 2, pp. 79–82.
Pu, H.F., Tan, S.K., Chen, H.L., Jea, J.C., and Liu, T.C., Neuroendocrinology, 1999, vol. 70, no. 5, pp. 324–331.
Meites, J., Clin. Endocrinol. (Oxf), 1977, vol. 6.
Honey, R.N. and Weir, G.C., Endocrinology, 1980, vol. 107, no. 4, pp. 1065–1068.
Robbins, R.J., Sutton, R.E., and Reichlin, S., Brain Res., 1982, vol. 234, no. 2, pp. 377–386.
Koop, H., Behrens, I., Bothe, E., McIntosh, C.H., Pederson, R.A., Arnold, R., and Creutzfeldt, W., Digestion, 1982, vol. 25, no. 2, pp. 96–102.
Krsmanovic, L.Z., Mores, N., Navarro, C.E., Saeed, S.A., Arora, K.K., and Catt, K.J., Endocrinology, 1998, vol. 139, no. 10, pp. 4037–4043.
Mitsuma, T., Hirooka, Y., Nakata, K., and Nogimori, T., Horm. Metab. Res., 1989, vol. 21, no. 1, pp. 8–10.
Lamberton, P., Wu, P., and Jackson, I.M., Endocrinology, 1834–1838, vol. 117, no. 5, P. 1834–1838.
Bazyan, A.S., Orlova, N.V., and Getsova, V.M., Zhurn. VND Im. I.P. Pavlova, 2000, vol. 50, no. 3, pp. 500–508.
Idova, G.V., Tezisy konf. “Neirokhimiya: Fundamental’nye i prikladnye aspekty” (Proceedings of Conference “Neurochemistry: Fundamental and Applied Aspects), Moscow, 2005, pp. 99.
Gordon, J. and Barnes, N.M., TRENDS in immunology, 2003, vol. 24, no. 8, pp. 438–443.
Daw, N.D., Kakade, S., and Dayan, P., Neural. Networks, 2002, vol. 15, nos. 4–6, pp. 603–616.
Ierusalimskii, V.N., Funktsional’naya regulyatsiya i ontogenez mediator-spetsifichnykh sistem neironov bespozvonochnykh:, Doctoral (Biol) Dissertation, Moscow: MGU., 2009.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © S.V. Koroleva, A.A. Nikolaeva, I.P. Ashmarin, 2012, published in Neirokhimiya, 2012, Vol. 29, No. 2, pp. 150–161.
Rights and permissions
About this article
Cite this article
Koroleva, S.V., Nikolaeva, A.A. & Ashmarin, I.P. Types of bioinformatic programs in the continuum of regulatory peptides and non-peptide mediators. Traits of interaction of dopamine and serotonin systems. Neurochem. J. 6, 132–143 (2012). https://doi.org/10.1134/S1819712412020031
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1819712412020031